• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Crescent Biopharma, Inc. - Common Stock (NQ:CBIO)

    17.34 +0.58 (+3.46%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 302,029
    Open 16.84
    Bid (Size) 17.34 (300)
    Ask (Size) 18.27 (200)
    Prev. Close 16.76
    Today's Range 16.34 - 17.61
    52wk Range 8.720 - 27.41
    Shares Outstanding 64,532,091
    Dividend Yield 2.77%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +56.5%
    +56.5%
    1 Month
    -3.7%
    -3.7%
    3 Month
    -9.2%
    -9.2%
    6 Month
    +58.1%
    +58.1%
    1 Year
    +17.2%
    +17.2%

    More News

    Read More
    News headline image
    Crescent Biopharma to Present at June Investor Conferences
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma to Present at May Investor Conferences
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    Which stocks are moving on Friday? ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma to Present at March Investor Conferences
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    The Deal That Sent Crescent Biopharma Shares Surging Over 40% Pre-Market Today ↗
    Via Stocktwits
    News headline image
    Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
    From Crescent Biopharma, Inc.
    Via GlobeNewswire
    News headline image
    Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
    From Crescent Biopharma, Inc.; Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
    Via GlobeNewswire
    News headline image
    Crescent Biopharma Announces Grants of Inducement Awards
    From Crescent Biopharma
    Via GlobeNewswire

    Frequently Asked Questions

    Is Crescent Biopharma, Inc. - Common Stock publicly traded?
    Yes, Crescent Biopharma, Inc. - Common Stock is publicly traded.
    What exchange does Crescent Biopharma, Inc. - Common Stock trade on?
    Crescent Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Crescent Biopharma, Inc. - Common Stock?
    The ticker symbol for Crescent Biopharma, Inc. - Common Stock is CBIO on the Nasdaq Stock Market
    What is the current price of Crescent Biopharma, Inc. - Common Stock?
    The current price of Crescent Biopharma, Inc. - Common Stock is 17.34
    When was Crescent Biopharma, Inc. - Common Stock last traded?
    The last trade of Crescent Biopharma, Inc. - Common Stock was at 07/10/26 04:00 PM ET
    What is the market capitalization of Crescent Biopharma, Inc. - Common Stock?
    The market capitalization of Crescent Biopharma, Inc. - Common Stock is 1.12B
    How many shares of Crescent Biopharma, Inc. - Common Stock are outstanding?
    Crescent Biopharma, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.